
‘Pharma Bro’ Martin Shkreli's companies file for bankruptcy
The company founded by Martin Shkreli, the “Pharma Bro” known for hiking the price of an old drug by 4,000%, has filed for Chapter 11 bankruptcy in Delaware.
Vyera Pharmaceuticals, which is the rebranded version of Shkreli’s Turing Pharmaceuticals, its parent company Phoenixus AG and four other companies filed for Chapter 11 protection on Wednesday, according to documents from the US Bankruptcy Court for the District of Delaware. The case filing for Vyera states that the pharma plans to have a sale or liquidation of the “liquidating debtors” and for Phoenixus to be preserved.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.